RB
Rahul D. Ballal (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Agios Pharmaceuticals, Inc. (AGIO). Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 8 2024
Filed Nov 12 2024
Median ADV $39.7M across their filed names
Open performance→Most traded names
AGIORecent filings
AGIOSALE
Agios Pharmaceuticals, Inc.
View filing →
$1.0M18,500 sh across 4 lots
Exec Nov 7 2024
Filed Nov 12 2024 · 5:30 PM ET